Stefan Koch

Senior Associate Professor Stefan Koch is affiliated with Linköping University's Department of Biomedical and Clinical Sciences (BKV), within the Division of Molecular Medicine and Virology. His primary research focuses on molecular mechanisms of cellular signaling in inflammatory disorders and cancer, particularly investigating how signaling pathways influence tissue injury, repair, and metastasis. Key projects include studying the roles of transcription factors like TBX3 and FOXQ1 in colorectal cancer and understanding Wnt/β-catenin signaling in disease progression.

His academic background and affiliations include membership in the Wallenberg Centre for Molecular Medicine at LiU, emphasizing medicine-technology interfaces. Koch's work bridges molecular biology and clinical applications, aiming to identify new therapeutic targets for cancer and inflammatory diseases. His research has led to significant publications in journals like Proceedings of the National Academy of Sciences and Cancer Metastasis Review.

Notable contributions include discoveries about embryonic signaling pathways in cancer aggressiveness and the role of p53 in regulating FOXQ1. He collaborates widely, as evidenced by co-authorships on high-impact studies.